RecruitingPhase 3ketamine

Effect of Ketamine on Intraoperative Motor Evoked Potentials

Sponsored by University of California, San Francisco

NCT ID
NCT06140927
Target Enrollment
20 participants
Start Date
2023-12-01
Est. Completion
2026-12-01

About This Study

The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.

Conditions Studied

Spine FusionSpine TumorSpinal Stenosis

Interventions

  • Ketamine

Eligibility

Age:18 Years - 100 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Adult patients (\>18 years of age) undergoing posterior spinal fusions.

Exclusion Criteria:

* Sensitivity or allergy to ketamine.
* Schizophrenia or other psychotic conditions
* Uncontrolled hypertension with systolic blood pressure greater than 180 mmHg
* Myocardial Infarction
* Large vascular aneurysms
* Patients on ketamine as outpatient therapy.

Study Locations (1)

University of California, San Francisco
San Francisco, California, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Marc Buren, MD
CONTACT
4154768369marc.buren@ucsf.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source